worst performing large cap stocks by year 2018

Summit Therapeutics (SMMT) had the worst year in 2018 by a large-cap US stock in 2018, returning -89.5%.

ASSET YEAR % RETURN
Summit Therapeutics (SMMT)
2018
-89.53%
Keurig Dr Pepper (KDP)
2018
-73.36%
Snap (SNAP)
2018
-62.49%
Flex (FLEX)
2018
-58.07%
Insmed (INSM)
2018
-58.03%
Deutsche Bank (DB)
2018
-57.26%
GE Aerospace (GE)
2018
-55.72%
Western Digital (WDC)
2018
-52.36%
Owens Corning (OC)
2018
-51.95%
Antero Resources (AR)
2018
-51.2%
Builders FirstSource (BLDR)
2018
-50.41%
JD Inc Adr (JD)
2018
-50.33%
British American Tobacco (BTI)
2018
-49.89%
Pilgrims Pride (PPC)
2018
-49.54%
PG&E (PCG)
2018
-46.44%
Unum (UNM)
2018
-45.76%
Devon Energy (DVN)
2018
-45.6%
Freeport-McMoran Copper & Gold (FCX)
2018
-45.37%
Schlumberger (SLB)
2018
-45.2%
Alamos Gold (AGI)
2018
-45%
Halliburton (HAL)
2018
-44.66%
Alnylam Pharmaceuticals (ALNY)
2018
-43.18%
Kraft Heinz (KHC)
2018
-42.59%
LKQ (LKQ)
2018
-42.18%
ConAgra Foods (CAG)
2018
-42%
Large-cap stocks are treated as having a market cap of $10B+.